Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Precise.ly was a private digital health and consumer genomics company developing a precision health platform to track, analyze, and securely manage personal health data. The company combined consumer genomics, next-generation sequencing data, and digital health workflows to generate individualized risk assessments and support more personalized, preventive care. Its early commercial focus included India, where it partnered with Narayana Health to deliver genomics services and enable clinical applications such as matched donor identification for stem cell transplantation. The company was founded by Linda Avey, Aneil Mallavarapu, Heather Anne Halpert, and Mitsuharu Hadeishi. Available secondary sources indicate the business later became inactive or out of business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Precise.ly.